• Hunter DJ, Bierma-Zeinstra S. Osteoarthritis. The Lancet. 2019;393(10182):1745–59.

    CAS 
    Article 

    Google Scholar
     

  • Neogi T. The epidemiology and impact of pain in osteoarthritis. Osteoarthr Cartil. 2013;21(9):1145–53.

    CAS 
    Article 

    Google Scholar
     

  • Liu A, Kendzerska T, Stanaitis I, Hawker G. The relationship between knee pain characteristics and symptom state acceptability in people with knee osteoarthritis. Osteoarthr Cartil. 2014;22(2):178–83.

    CAS 
    Article 

    Google Scholar
     

  • Malfait A, Schnitzer T. Towards a mechanism-based approach to pain management in osteoarthritis. Nat Rev Rheumatol. 2013;9(11):654–64.

    CAS 
    Article 

    Google Scholar
     

  • Dimitroulas T, Duarte R, Behura A, Kitas G, Raphael J. Neuropathic pain in osteoarthritis: a review of pathophysiological mechanisms and implications for treatment. Semin Arthritis Rheum. 2014;44(2):145–54.

    Article 

    Google Scholar
     

  • Lluch E, Torres R, Nijs J, Van Oosterwijck J. Evidence for central sensitization in patients with osteoarthritis pain: a systematic literature review. Eur J Pain. 2014;18(10):1367–75.

    CAS 
    Article 

    Google Scholar
     

  • Osani M, Vaysbrot E, Zhou M, McAlindon T, Bannuru R. Duration of symptom relief and early trajectory of adverse events for oral nonsteroidal antiinflammatory drugs in knee osteoarthritis: a systematic review and meta-analysis. Arthritis Care Res. 2020;72(5):641–51.

    Article 

    Google Scholar
     

  • He W, Kuang M, Zhao J, Sun L, Lu B, Wang Y, et al. Efficacy and safety of intraarticular hyaluronic acid and corticosteroid for knee osteoarthritis: a meta-analysis. Int J Surg (Lond, Engl). 2017;39:95–103.

    Article 

    Google Scholar
     

  • Yang S, Huang Y, Ye Z, Li L, Zhang Y. The efficacy of nerve growth factor antibody for the treatment of osteoarthritis pain and chronic low-back pain: a meta-analysis. Front Pharmacol. 2020;11:817.

    CAS 
    Article 

    Google Scholar
     

  • Uchio Y, Enomoto H, Alev L, Kato Y, Ishihara H, Tsuji T, et al. A randomized, double-blind, placebo-controlled Phase III trial of duloxetine in Japanese patients with knee pain due to osteoarthritis. J Pain Res. 2018;11:809–21.

    CAS 
    Article 

    Google Scholar
     

  • Rock D, Kelly K, Macdonald R. Gabapentin actions on ligand- and voltage-gated responses in cultured rodent neurons. Epilepsy Res. 1993;16(2):89–98.

    CAS 
    Article 

    Google Scholar
     

  • Gee N, Brown J, Dissanayake V, Offord J, Thurlow R, Woodruff G. The novel anticonvulsant drug, gabapentin (Neurontin), binds to the alpha2delta subunit of a calcium channel. J Biol Chem. 1996;271(10):5768–76.

    CAS 
    Article 

    Google Scholar
     

  • Chiechio S, Zammataro M, Caraci F, Rampello L, Copani A, Sabato AF, et al. Pregabalin in the treatment of chronic pain: an overview. Clin Drug Investig. 2009;29(3):203–13.

    CAS 
    Article 

    Google Scholar
     

  • Higgins JP, Altman DG, Gotzsche PC, Juni P, Moher D, Oxman AD, et al. The Cochrane Collaboration’s tool for assessing risk of bias in randomised trials. BMJ. 2011;343:d5928.

    Article 

    Google Scholar
     

  • Sofat N, Harrison A, Russell MD, Ayis S, Kiely PD, Baker EH, et al. The effect of pregabalin or duloxetine on arthritis pain: a clinical and mechanistic study in people with hand osteoarthritis. J Pain Res. 2017;10:2437–49.

    CAS 
    Article 

    Google Scholar
     

  • Altman R, Alarcón G, Appelrouth D, Bloch D, Borenstein D, Brandt K, et al. The American College of Rheumatology criteria for the classification and reporting of osteoarthritis of the hand. Arthritis Rheum. 1990;33(11):1601–10.

    CAS 
    Article 

    Google Scholar
     

  • Ohtori S, Inoue G, Orita S, Takaso M, Eguchi Y, Ochiai N, et al. Efficacy of combination of meloxicam and pregabalin for pain in knee osteoarthritis. Yonsei Med J. 2013;54(5):1253–8.

    CAS 
    Article 

    Google Scholar
     

  • Enteshari-Moghaddam A, Azami A, Isazadehfar K, Mohebbi H, Habibzadeh A, Jahanpanah P. Efficacy of duloxetine and gabapentin in pain reduction in patients with knee osteoarthritis. Clin Rheumatol. 2019;38(10):2873–80.

    Article 

    Google Scholar
     

  • Schaible H. Nociceptive neurons detect cytokines in arthritis. Arthritis Res Ther. 2014;16(5):470.

    Article 

    Google Scholar
     

  • Pinho-Ribeiro F, Verri W, Chiu I. Nociceptor sensory neuron-immune interactions in pain and inflammation. Trends Immunol. 2017;38(1):5–19.

    CAS 
    Article 

    Google Scholar
     

  • Ji RR, Chamessian A, Zhang YQ. Pain regulation by non-neuronal cells and inflammation. Science. 2016;354(6312):572.

    CAS 
    Article 

    Google Scholar
     

  • Fu K, Robbins SR, McDougall JJ. Osteoarthritis: the genesis of pain. Rheumatology (Oxford). 2018;57(suppl_4):iv43–50.

    CAS 
    Article 

    Google Scholar
     

  • Cohen SP, Mao J. Neuropathic pain: mechanisms and their clinical implications. BMJ. 2014;348:f7656.

    Article 

    Google Scholar
     

  • Komori K, Nonaka T, Okada A, Kinoh H, Hayashita-Kinoh H, Yoshida N, et al. Absence of mechanical allodynia and Abeta-fiber sprouting after sciatic nerve injury in mice lacking membrane-type 5 matrix metalloproteinase. FEBS Lett. 2004;557:125–8.

    CAS 
    Article 

    Google Scholar
     

  • Mease PJ, Hanna S, Frakes EP, Altman RD. Pain mechanisms in osteoarthritis: understanding the role of central pain and current approaches to its treatment. J Rheumatol. 2011;38(8):1546–51.

    CAS 
    Article 

    Google Scholar
     

  • Conaghan PG, Cook AD, Hamilton JA, Tak PP. Therapeutic options for targeting inflammatory osteoarthritis pain. Nat Rev Rheumatol. 2019;15(6):355–63.

    Article 

    Google Scholar
     

  • Patel R, Dickenson AH. Mechanisms of the gabapentinoids and alpha 2 delta-1 calcium channel subunit in neuropathic pain. Pharmacol Res Perspect. 2016;4(2):e00205.

    Article 

    Google Scholar
     

  • Colloca L, Ludman T, Bouhassira D, Baron R, Dickenson A, Yarnitsky D, et al. Neuropathic pain. Nat Rev Disease Primers. 2017;3:17002.

    Article 

    Google Scholar
     

  • Stahl S, Porreca F, Taylor C, Cheung R, Thorpe A, Clair A. The diverse therapeutic actions of pregabalin: Is a single mechanism responsible for several pharmacological activities? Trends Pharmacol Sci. 2013;34(6):332–9.

    CAS 
    Article 

    Google Scholar
     

  • Takeuchi Y, Takasu K, Ono H, Tanabe M. Pregabalin, S-(+)-3-isobutylgaba, activates the descending noradrenergic system to alleviate neuropathic pain in the mouse partial sciatic nerve ligation model. Neuropharmacology. 2007;53(7):842–53.

    CAS 
    Article 

    Google Scholar
     

  • Suzuki R, Dickenson A. Differential pharmacological modulation of the spontaneous stimulus-independent activity in the rat spinal cord following peripheral nerve injury. Exp Neurol. 2006;198(1):72–80.

    CAS 
    Article 

    Google Scholar
     

  • Hayashida K, Eisenach J. Multiplicative interactions to enhance gabapentin to treat neuropathic pain. Eur J Pharmacol. 2008;598:21–6.

    CAS 
    Article 

    Google Scholar
     

  • Yoshizumi M, Parker RA, Eisenach JC, Hayashida K. Gabapentin inhibits γ-amino butyric acid release in the locus coeruleus but not in the spinal dorsal horn after peripheral nerve injury in rats. Anesthesiology. 2012;116(6):1347–53.

    CAS 
    Article 

    Google Scholar
     

  • Bannister K, Qu C, Navratilova E, Oyarzo J, Xie J, King T, et al. Multiple sites and actions of gabapentin-induced relief of ongoing experimental neuropathic pain. Pain. 2017;158(12):2386–95.

    CAS 
    Article 

    Google Scholar
     

  • Rights and permissions

    Open Access This article is licensed under a Creative Commons Attribution 4.0 International License, which permits use, sharing, adaptation, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons licence, and indicate if changes were made. The images or other third party material in this article are included in the article’s Creative Commons licence, unless indicated otherwise in a credit line to the material. If material is not included in the article’s Creative Commons licence and your intended use is not permitted by statutory regulation or exceeds the permitted use, you will need to obtain permission directly from the copyright holder. To view a copy of this licence, visit http://creativecommons.org/licenses/by/4.0/. The Creative Commons Public Domain Dedication waiver (http://creativecommons.org/publicdomain/zero/1.0/) applies to the data made available in this article, unless otherwise stated in a credit line to the data.

    Disclaimer:

    This article is autogenerated using RSS feeds and has not been created or edited by OA JF.

    Click here for Source link (https://www.biomedcentral.com/)